Louisiana 2013 Regular Session

Louisiana Senate Bill SR175

Introduced
6/3/13  
Introduced
6/3/13  
Passed
6/4/13  

Caption

Requests DHH to study the most effective means by which to ensure open access to HIV/AIDS and hepatitis C medication by persons enrolled in Medicaid managed care.

Impact

This resolution highlights the critical intersection of public health policy and healthcare access, particularly for individuals dealing with chronic conditions such as HIV/AIDS and hepatitis C. By prompting the DHH to examine how to improve access to medications, the resolution aims to mitigate barriers that currently exist within the Bayou Health framework. If enacted, the measures derived from this study could lead to legislative changes impacting pharmacy regulations and Medicaid policies related to pharmaceutical access.

Summary

Senate Resolution 175, proposed by Senator Broome, urges the Louisiana Department of Health and Hospitals (DHH) to study effective means for ensuring open access to HIV/AIDS and hepatitis C medications for individuals enrolled in the Bayou Health Medicaid managed care program. The resolution seeks to address concerns related to the lack of transparency and public input in the development of drug formularies used by private insurance companies managing this program. Stakeholders believe that easier access to these medications is crucial for effective disease management and overall health outcomes for vulnerable populations.

Sentiment

The sentiment surrounding SR175 appears supportive, as it addresses a significant public health issue by advocating for better access to essential medications. Legislators concerned with healthcare access and disease management are likely to view the resolution favorably. However, it also opens the door for potential criticism regarding limitations in the current system, as it underscores existing weaknesses in the delivery of care under the Bayou Health program.

Contention

While the resolution itself is largely uncontroversial, the dialogues it initiates may uncover tensions regarding how healthcare is managed and administered within the Medicaid system. Opponents may argue that the current approach by Bayou Health could be improved without needing state investigation, while proponents assert that the need for access to critical medications justifies such a study. Ultimately, this resolution sets the stage for broader discussions on health equity and access to necessary treatment across the state.

Companion Bills

No companion bills found.

Previously Filed As

LA HR164

Requests DHH to study the most effective means by which to ensure open access to HIV/AIDS and hepatitis C medications by persons enrolled in Medicaid managed care

LA HR211

Requests DHH to study means for improving access to and reliability of medical transportation for Medicaid enrollees

LA HR218

Urges and requests DHH to study the feasibility and impact of requiring Medicaid providers to offer hepatitis C and HIV testing

LA HCR75

Requires transparency in Medicaid managed care programs operated by DHH

LA HCR113

Requests a study of the most effective means by which to implement federally authorized cost sharing measures in the La. Medicaid program

LA HCR15

Requests a study of the most effective means by which to reduce Louisiana's rate of suicide

LA HB704

Provides relative to the Louisiana Commission on HIV, AIDS, and Hepatitis C

LA HCR96

Requests a study of means by which to expand access to telehealth services in La.

LA HB3367

Poor persons; ensuring access to Medicaid Act; definition; effective date.

LA SF404

Medical assistance enrollees permission to opt out of managed care enrollment

Similar Bills

No similar bills found.